Heparin-binding EGF-like growth factor in the human prostate

Synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen

Michael R. Freeman, Subroto Paul, Martin Kaefer, Masakazu Ishikawa, Rosalyn M. Adam, Andrew A. Renshaw, Klaus Elenius, Michael Klagsbrun

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is an activating ligand for the EGF receptor (HER1/ErbB1) and the high-affinity receptor for diphtheria toxin (DT) in its transmembrane form (proHB-EGF). HB- EGF was immunolocalized within human benign and malignant prostatic tissues, using monospecific antibodies directed against the mature protein and against the cytoplasmic domain of proHB-EGF. Prostate carcinoma cells, normal glandular epithelial cells, undifferentiated fibroblasts, and inflammatory cells were not decorated by the anti-HB-EGF antibodies; however, interstitial and vascular smooth muscle cells were highly reactive, indicating that the smooth muscle compartments are the major sites of synthesis and localization of HB-EGF within the prostate. In marked contrast to prostatic epithelium, proHB-EGF was immunolocalized to seminal vesicle epithelium, indicating differential regulation of HB-EGF synthesis within various epithelia of the reproductive tract. HB-EGF was not overexpressed in this series of cancer tissues, in comparison to the benign tissues. In experiments with LNCaP human prostate carcinoma cells, HB-EGF was similar in potency to epidermal growth factor (EGF) in stimulating cell growth. Exogenous HB-EGF and EGF each activated HER1 and HER3 receptor tyrosine kinases and induced tyrosine phosphorylation of cellular proteins to a similar extent. LNCaP cells expressed detectable but low levels of HB-EGF mRNA; however, proHB-EGF was detected at the cell surface indirectly by demonstration of specific sensitivity to DT. HB-EGF is the first HER1 ligand to be identified predominantly as a smooth muscle cell product in the human prostate. Further, the observation that HB-EGF is similar to EGF in mitogenic potency for human prostate carcinoma cells suggests that it may be one of the hypothesized stromal mediators of prostate cancer growth.

Original languageEnglish (US)
Pages (from-to)328-338
Number of pages11
JournalJournal of Cellular Biochemistry
Volume68
Issue number3
DOIs
StatePublished - Mar 1 1998
Externally publishedYes

Fingerprint

Vascular Smooth Muscle
Mitogens
Epidermal Growth Factor
Smooth Muscle Myocytes
Muscle
Heparin
Prostate
Intercellular Signaling Peptides and Proteins
Cells
Carcinoma
Epithelium
Tissue
Ligands
Diphtheria Toxin
Phosphorylation
Antibodies
Seminal Vesicles
Receptor Protein-Tyrosine Kinases
Cell growth
Fibroblasts

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Heparin-binding EGF-like growth factor in the human prostate : Synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen. / Freeman, Michael R.; Paul, Subroto; Kaefer, Martin; Ishikawa, Masakazu; Adam, Rosalyn M.; Renshaw, Andrew A.; Elenius, Klaus; Klagsbrun, Michael.

In: Journal of Cellular Biochemistry, Vol. 68, No. 3, 01.03.1998, p. 328-338.

Research output: Contribution to journalArticle

Freeman, Michael R. ; Paul, Subroto ; Kaefer, Martin ; Ishikawa, Masakazu ; Adam, Rosalyn M. ; Renshaw, Andrew A. ; Elenius, Klaus ; Klagsbrun, Michael. / Heparin-binding EGF-like growth factor in the human prostate : Synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen. In: Journal of Cellular Biochemistry. 1998 ; Vol. 68, No. 3. pp. 328-338.
@article{61b1f0fac25c49d0838cbaf4e475eb46,
title = "Heparin-binding EGF-like growth factor in the human prostate: Synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen",
abstract = "Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is an activating ligand for the EGF receptor (HER1/ErbB1) and the high-affinity receptor for diphtheria toxin (DT) in its transmembrane form (proHB-EGF). HB- EGF was immunolocalized within human benign and malignant prostatic tissues, using monospecific antibodies directed against the mature protein and against the cytoplasmic domain of proHB-EGF. Prostate carcinoma cells, normal glandular epithelial cells, undifferentiated fibroblasts, and inflammatory cells were not decorated by the anti-HB-EGF antibodies; however, interstitial and vascular smooth muscle cells were highly reactive, indicating that the smooth muscle compartments are the major sites of synthesis and localization of HB-EGF within the prostate. In marked contrast to prostatic epithelium, proHB-EGF was immunolocalized to seminal vesicle epithelium, indicating differential regulation of HB-EGF synthesis within various epithelia of the reproductive tract. HB-EGF was not overexpressed in this series of cancer tissues, in comparison to the benign tissues. In experiments with LNCaP human prostate carcinoma cells, HB-EGF was similar in potency to epidermal growth factor (EGF) in stimulating cell growth. Exogenous HB-EGF and EGF each activated HER1 and HER3 receptor tyrosine kinases and induced tyrosine phosphorylation of cellular proteins to a similar extent. LNCaP cells expressed detectable but low levels of HB-EGF mRNA; however, proHB-EGF was detected at the cell surface indirectly by demonstration of specific sensitivity to DT. HB-EGF is the first HER1 ligand to be identified predominantly as a smooth muscle cell product in the human prostate. Further, the observation that HB-EGF is similar to EGF in mitogenic potency for human prostate carcinoma cells suggests that it may be one of the hypothesized stromal mediators of prostate cancer growth.",
author = "Freeman, {Michael R.} and Subroto Paul and Martin Kaefer and Masakazu Ishikawa and Adam, {Rosalyn M.} and Renshaw, {Andrew A.} and Klaus Elenius and Michael Klagsbrun",
year = "1998",
month = "3",
day = "1",
doi = "10.1002/(SICI)1097-4644(19980301)68:3<328::AID-JCB4>3.0.CO;2-W",
language = "English (US)",
volume = "68",
pages = "328--338",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Heparin-binding EGF-like growth factor in the human prostate

T2 - Synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen

AU - Freeman, Michael R.

AU - Paul, Subroto

AU - Kaefer, Martin

AU - Ishikawa, Masakazu

AU - Adam, Rosalyn M.

AU - Renshaw, Andrew A.

AU - Elenius, Klaus

AU - Klagsbrun, Michael

PY - 1998/3/1

Y1 - 1998/3/1

N2 - Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is an activating ligand for the EGF receptor (HER1/ErbB1) and the high-affinity receptor for diphtheria toxin (DT) in its transmembrane form (proHB-EGF). HB- EGF was immunolocalized within human benign and malignant prostatic tissues, using monospecific antibodies directed against the mature protein and against the cytoplasmic domain of proHB-EGF. Prostate carcinoma cells, normal glandular epithelial cells, undifferentiated fibroblasts, and inflammatory cells were not decorated by the anti-HB-EGF antibodies; however, interstitial and vascular smooth muscle cells were highly reactive, indicating that the smooth muscle compartments are the major sites of synthesis and localization of HB-EGF within the prostate. In marked contrast to prostatic epithelium, proHB-EGF was immunolocalized to seminal vesicle epithelium, indicating differential regulation of HB-EGF synthesis within various epithelia of the reproductive tract. HB-EGF was not overexpressed in this series of cancer tissues, in comparison to the benign tissues. In experiments with LNCaP human prostate carcinoma cells, HB-EGF was similar in potency to epidermal growth factor (EGF) in stimulating cell growth. Exogenous HB-EGF and EGF each activated HER1 and HER3 receptor tyrosine kinases and induced tyrosine phosphorylation of cellular proteins to a similar extent. LNCaP cells expressed detectable but low levels of HB-EGF mRNA; however, proHB-EGF was detected at the cell surface indirectly by demonstration of specific sensitivity to DT. HB-EGF is the first HER1 ligand to be identified predominantly as a smooth muscle cell product in the human prostate. Further, the observation that HB-EGF is similar to EGF in mitogenic potency for human prostate carcinoma cells suggests that it may be one of the hypothesized stromal mediators of prostate cancer growth.

AB - Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is an activating ligand for the EGF receptor (HER1/ErbB1) and the high-affinity receptor for diphtheria toxin (DT) in its transmembrane form (proHB-EGF). HB- EGF was immunolocalized within human benign and malignant prostatic tissues, using monospecific antibodies directed against the mature protein and against the cytoplasmic domain of proHB-EGF. Prostate carcinoma cells, normal glandular epithelial cells, undifferentiated fibroblasts, and inflammatory cells were not decorated by the anti-HB-EGF antibodies; however, interstitial and vascular smooth muscle cells were highly reactive, indicating that the smooth muscle compartments are the major sites of synthesis and localization of HB-EGF within the prostate. In marked contrast to prostatic epithelium, proHB-EGF was immunolocalized to seminal vesicle epithelium, indicating differential regulation of HB-EGF synthesis within various epithelia of the reproductive tract. HB-EGF was not overexpressed in this series of cancer tissues, in comparison to the benign tissues. In experiments with LNCaP human prostate carcinoma cells, HB-EGF was similar in potency to epidermal growth factor (EGF) in stimulating cell growth. Exogenous HB-EGF and EGF each activated HER1 and HER3 receptor tyrosine kinases and induced tyrosine phosphorylation of cellular proteins to a similar extent. LNCaP cells expressed detectable but low levels of HB-EGF mRNA; however, proHB-EGF was detected at the cell surface indirectly by demonstration of specific sensitivity to DT. HB-EGF is the first HER1 ligand to be identified predominantly as a smooth muscle cell product in the human prostate. Further, the observation that HB-EGF is similar to EGF in mitogenic potency for human prostate carcinoma cells suggests that it may be one of the hypothesized stromal mediators of prostate cancer growth.

UR - http://www.scopus.com/inward/record.url?scp=0032030792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032030792&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4644(19980301)68:3<328::AID-JCB4>3.0.CO;2-W

DO - 10.1002/(SICI)1097-4644(19980301)68:3<328::AID-JCB4>3.0.CO;2-W

M3 - Article

VL - 68

SP - 328

EP - 338

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 3

ER -